Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAACT-PV: Treatment of Uncomplicated P. Vivax Malaria in Pregnant Women
NCT01107145Phase 4Terminated
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Feb 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artemether, lumefantrine, artesunate, mefloquine in Plasmodium vivax malaria, sponsored by Centers for Disease Control and Prevention. Started Feb 2011; status: terminated.
02
Drugs
artemetherlumefantrineartesunatemefloquine
03
Conditions
Plasmodium vivax malaria
Beyond the preview
Go deeper on NCT01107145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01107145.